Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
search
Subscribe
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
Subscribe
FREE
29 Oct 2024
How Estrogen Weakens Immune Defenses in Cancer
A recent study sheds light on how estrogen signaling affects immune response in breast cancer, potentially opening pathways for combined anti-estrogen and immunotherapy approaches.
28 Oct 2024
Immune Therapy Shows Cancer-Free Survival For 10 Years
Nearly half of patients with metastatic melanoma treated with a combination of the immune checkpoint inhibitors nivolumab and ipilimumab have survived cancer-free, underscoring the impact of immunotherapy in advanced melanoma.
28 Oct 2024
Duloxetine Recalled Due to Cancer Risks
Duloxetine, a widely used and popular antidepressant, has been recalled by U.S. Food and Drug Administration (FDA) due to the detection of N-nitroso-duloxetine, a chemical suspected of being carcinogenic.
27 Oct 2024
Chronic Pain Progresses 1 Year After Whiplash Injury
Hippocampal functional connectivity may be an early indicator of chronic pain development in patients following whiplash and mild traumatic brain injuries (mTBIs) according to the results of a new study.
26 Oct 2024
Tusi: Mysterious New Drug Trend Rising
Tusi, a new drug blend also known as “pink cocaine,” is gaining traction across Latin America, Europe, and more recently, in the United States.
25 Oct 2024
E. coli
Outbreak in 6 States: CDC Latest
The CDC has issued a health alert linking a multistate Escherichia coli (E. coli) outbreak to McDonald’s Quarter Pounders; the outbreak has spanned six states, with one death and numerous hospitalizations reported.
25 Oct 2024
Study Shows Ozempic Reduced Opioid Overdose By 40%
Prescribed drugs for diabetes may also reduce the risk of opioid overdoses and alcohol intoxication in patients struggling with addiction according to the results of a new study.
24 Oct 2024
CDC Warns of Oropouche Virus Sexual Transmission Risk
Ninety cases of imported Oropouche virus have been reported across five states, primarily in Florida, according to the U.S. Centers for Disease Control and Prevention (CDC).
24 Oct 2024
Avian Flu and Mpox: Emerging Pandemic Risks
The Global Preparedness Monitoring Board (GPMB) has released its latest annual report, spotlighting avian flu and mpox as significant emerging threats with pandemic potential.
23 Oct 2024
Lupus in Pregnancy Linked to Placental Damage
Systemic lupus erythematosus impacts placental health, particularly in pregnancies resulting in small for gestational age infants.
←
1
2
3
…
105
106
107
108
109
110
111
…
128
129
130
→
We’ve noticed you’re accessing
from
North/South America.
View
View